New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
09:55 EDTALXN, ALXNDeutsche Bank biotech analyst holds an analyst/industry conference call
Biotech Analyst Karnauskas, along with Dr. David Kuter, discuss Alexion Pharmaceuticals' Soliris, the potential for follow-on products and the competition on an Analyst/Industry conference call to be held on June 11 at 10:30 am.
News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
07:44 EDTALXNAlexion valuation looking increasingly compelling, says Stifel
Subscribe for More Information
July 24, 2014
11:53 EDTALXNAlexion price target raised to $214 from $196 at Piper Jaffray
Subscribe for More Information
06:43 EDTALXNAlexion raises 2014 adjusted EPS view to $4.95-$5.05 from $4.75-$4.85
Subscribe for More Information
06:41 EDTALXNAlexion reports Q2 adjusted EPS $1.12, consensus $1.07
Subscribe for More Information
06:17 EDTALXNAlexion's hypophosphatasia candidate MAA accepted by European Medicines Agency
Subscribe for More Information
July 22, 2014
11:48 EDTALXNStocks with call strike movement; EXPE ALXN
Subscribe for More Information
July 16, 2014
10:01 EDTALXNPegasystems appoints Warner Chief Compliance Officer
Subscribe for More Information
08:01 EDTALXNAlexion names former AstraZeneca CEO David Brennan to board
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use